Acolyte and Berthold form Marketing Alliance
News Jun 05, 2006
Berthold Technologies GmbH & Co. KG will support distribution of Acolyte’s BacLite® RapiTECT range of enumeration assays in Europe and the United States.
The BacLite® range currently includes BacLite® RapiTECT GRAM NEGATIVE (GN)™ for the rapid detection and enumeration of gram negative bacterial cells and BacLite® RapiTECT Mammalian (M)™ for the rapid enumeration of mammalian cells.
The BacLite® RapiTECT assay range uses adenylate kinase (AK) as a highly sensitive marker of viable cells.
Previous research has demonstrated that AK enhances the sensitivity of cell enumeration and acts as a reliable reporter of viable cells than ATP bioluminescence.
Unlike ATP, AK is present at relatively constant levels in viable cells and can be used to count cells at very low levels due to the ADP»ATP amplification process.
This AK rapid® technology is up to 100 times more sensitive than standard ATP bioluminescence and up to 1 million times more sensitive than optical measurements.
Applications for the BacLite® RapiTECT GRAM NEGATIVE (GN)™ assay include bacterial growth and inhibition studies, anti-microbial research and a range of other microbiological, bio-processing and pharmacological applications.
The BacLite® RapiTECT MAMMALIAN (M)™ assay can be used in drug discovery, bioengineering, bio-processing and genetic research as well as many areas of academic and institution based research.
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE